Medivation
Medivation was an American biopharmaceutical company.
Areas of interest[edit | edit source]
It is focused on rapid development of novel therapies to treat serious diseases for which there are limited treatment options.
Location[edit | edit source]
Medivation was headquartered in San Francisco, California.
History[edit | edit source]
The company began operations in December 2004 with the acquisition of Medivation neurology, Inc.
CEO[edit | edit source]
Its final CEO was David Hung.
Acquisition by Pfizer[edit | edit source]
Pfizer announced it would acquire the company in August 2016, and completed the acquisition in October 2016.
Website[edit | edit source]
- Need help finding a doctor or specialist anywhere in the world? WikiMD's DocFinder can help with millions of doctors!
| This article is a stub. Help WikiMD grow by registering to expand it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.- American companies established in 2004
- Companies formerly listed on the Nasdaq
- Companies based in San Francisco
- Technology companies based in the San Francisco Bay Area
- Biotechnology companies of the United States
- Biotechnology companies established in 2004
- Pfizer
- 2016 mergers and acquisitions
- Biopharmaceutical companies
- Pharmaceutical companies established in 2004
- Pharmaceutical companies of the United States
Contributors: Admin, Prab R. Tumpati, MD
